Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,000
Closed -$1.05M 1175
2025
Q4
$1.05M Hold
10,000
0.01% 400
2025
Q3
$839K Hold
10,000
0.01% 386
2025
Q2
$792K Buy
+10,000
New +$795K 0.01% 315

Other funds holding MRK

Marex Group's MRK Position: Q2 2026 in Review

Marex Group increased its Merck (MRK) stake by 22% in Q2 2026, buying an estimated $282K and bringing the position to 13,315 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #400.

Marex Group first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2023. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Marex Group held 13,315 shares of Merck worth $1.71M as of Q2 2026.
  • Marex Group bought 2,411 Merck shares in Q2 2026, an estimated $282K.
  • Merck made up 0.01% of Marex Group's portfolio in Q2 2026, its #400 holding.
  • Marex Group first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Marex Group's Merck position peaked at $13.7M in Q4 2023.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.